Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3439)
All Articles published online
|
Apr 15, 2010 (publication date) through Oct 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu LG. Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis. World J Gastrointest Oncol 2010; 2(4): 177-180 [PMID: 21160594 DOI: 10.4251/wjgo.v2.i4.177] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v2/i4/177.htm |
| Number | Citing Articles |
| 1 |
Mohammad Anjum Shaik, Wai Tham Hong-. Emerging Role of Galectins as Molecular Targets for Cancer Therapy: A Review. Malaysian Journal of Medicine and Health Sciences 2023; 19(5): 378 doi: 10.47836/mjmhs.19.5.43
|
| 2 |
R.J. Slack, R. Mills, A.C. Mackinnon. The therapeutic potential of galectin-3 inhibition in fibrotic disease. The International Journal of Biochemistry & Cell Biology 2021; 130: 105881 doi: 10.1016/j.biocel.2020.105881
|
| 3 |
Scott A. Barman, Zsuzsanna Bordan, Robert Batori, Stephen Haigh, David J. R. Fulton. Lung Inflammation in Health and Disease, Volume I. Advances in Experimental Medicine and Biology 2021; 1303: 13 doi: 10.1007/978-3-030-63046-1_2
|
| 4 |
Marina Rodrigues Tavares, Markéta Bláhová, Lieselotte Sedláková, Lothar Elling, Helena Pelantová, Rafał Konefał, Tomáš Etrych, Vladimír Křen, Pavla Bojarová, Petr Chytil. High-Affinity N-(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N-Acetyllactosamine Presentation Discriminate between Galectins. Biomacromolecules 2020; 21(2): 641 doi: 10.1021/acs.biomac.9b01370
|
| 5 |
Qicheng Zhao, Carrie A. Duckworth, Weikun Wang, Xiuli Guo, Hannah Barrow, D.Mark Pritchard, Jonathan M. Rhodes, Lu-Gang Yu. Peanut agglutinin appearance in the blood circulation after peanut ingestion mimics the action of endogenous galectin-3 to promote metastasis by interaction with cancer-associated MUC1. Carcinogenesis 2014; 35(12): 2815 doi: 10.1093/carcin/bgu216
|
| 6 |
Rakin Ahmed, Khairul Anam, Hafiz Ahmed. Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases. International Journal of Molecular Sciences 2023; 24(9): 8116 doi: 10.3390/ijms24098116
|
| 7 |
Iga Grochoła-Małecka, Paulina Czajka-Francuz, Aleksander Owczarek, Jerzy Wojnar, Gabriela Handzlik, Tomasz Francuz, Jerzy Chudek. Serum levels of VEGF-A, sVEGFR-2 and galectin-3 do not correlate with clinical stage, tumor size,
or effectiveness of perioperative chemotherapy in patients with non-metastatic breast cancer. Annales Academiae Medicae Silesiensis 2022; 76: 96 doi: 10.18794/aams/149208
|
| 8 |
Hannah Barrow, Jonathan M. Rhodes, Lu-Gang Yu. Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients. Cellular Oncology 2013; 36(1): 9 doi: 10.1007/s13402-012-0109-1
|
| 9 |
Zhanqi Cao, Zhaojun Hao, Ming Xin, Lugang Yu, Lei Wang, Ying Zhang, Xinke Zhang, Xiuli Guo. Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44. Laboratory Investigation 2018; 98(12): 1642 doi: 10.1038/s41374-018-0119-3
|
| 10 |
Yuichi Uchino, Ashley M. Woodward, Jérôme Mauris, Kristoffer Peterson, Priya Verma, Ulf J. Nilsson, Jaya Rajaiya, Pablo Argüeso. Galectin‐3 is an amplifier of the interleukin‐1β‐mediated inflammatory response in corneal keratinocytes. Immunology 2018; 154(3): 490 doi: 10.1111/imm.12899
|
| 11 |
Martina Sundqvist, Kristina Andelid, Ann Ekberg-Jansson, Johan Bylund, Anna Karlsson-Bengtsson, Anders Lindén. Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis: The Impact of Exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 2021; : 367 doi: 10.2147/COPD.S283372
|
| 12 |
Marwan Abdelmahmoud Abdelkarim Maki, Palanirajan Vijayaraj Kumar, Manogaran Elumalai, Omer Bayazeid. In silico-based Approach to Investigate the Ability of PEGylated Rapamycin to Inhibit Galectin-3. Current Drug Discovery Technologies 2021; 18(3): 451 doi: 10.2174/1570163817666200122162042
|
| 13 |
Siriwat Sukphokkit, Pichamon Kiatwuthinon, Supeecha Kumkate, Tavan Janvilisri. Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localization. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.999158
|
| 14 |
Isaac Eliaz. The Role of Galectin-3 as a Marker of Cancer and Inflammation in a Stage IV Ovarian Cancer Patient with Underlying Pro-Inflammatory Comorbidities. Case Reports in Oncology 2013; 6(2): 343 doi: 10.1159/000353574
|
| 15 |
Tianyu Liang, Zheng Zhu, Fangxiao Gong, Xiaobo Yang, Xiaoju Lei, Ling Lu. Galectin-3 promotes brain injury by modulating the phenotype of microglia via binding TLR-4 after intracerebral hemorrhage. Aging 2023; 15(17): 9041 doi: 10.18632/aging.205014
|
| 16 |
Lei Wang, Ying-Shuang Li, Lu-Gang Yu, Xin-Ke Zhang, Lin Zhao, Fu-Lian Gong, Xiao-Xia Yang, Xiu-Li Guo. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression. Biochemical Pharmacology 2020; 178: 114113 doi: 10.1016/j.bcp.2020.114113
|
| 17 |
Lynda Vuong, Eleni Kouverianou, Claire M. Rooney, Brian J. McHugh, Sarah E.M. Howie, Christopher D. Gregory, Stuart J. Forbes, Neil C. Henderson, Fredrik R. Zetterberg, Ulf J. Nilsson, Hakon Leffler, Paul Ford, Anders Pedersen, Lise Gravelle, Susan Tantawi, Hans Schambye, Tariq Sethi, Alison C. MacKinnon. An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade. Cancer Research 2019; 79(7): 1480 doi: 10.1158/0008-5472.CAN-18-2244
|
| 18 |
Martina Sundqvist, Veronica Osla, Bo Jacobsson, Anna Rudin, Karin Sävman, Anna Karlsson. Cord blood neutrophils display a galectin-3 responsive phenotype accentuated by vaginal delivery. BMC Pediatrics 2013; 13(1) doi: 10.1186/1471-2431-13-128
|
| 19 |
Gordana D. Radosavljevic, Jelena Pantic, Ivan Jovanovic, Miodrag L. Lukic, Nebojsa Arsenijevic. The Two Faces of Galectin-3: Roles in Various Pathological Conditions. Serbian Journal of Experimental and Clinical Research 2016; 17(3): 187 doi: 10.1515/sjecr-2016-0011
|
| 20 |
Martina Sundqvist, Amanda Welin, Jonas Elmwall, Veronica Osla, Ulf J Nilsson, Hakon Leffler, Johan Bylund, Anna Karlsson. Galectin-3 type-C self-association on neutrophil surfaces; The carbohydrate recognition domain regulates cell function. Journal of Leukocyte Biology 2018; 103(2): 341 doi: 10.1002/JLB.3A0317-110R
|
| 21 |
Norhan B.B. Mohammed, Lee Seng Lau, Joseph Souchak, Shi Qiu, Manmeet S. Ahluwalia, Iman Osman, Charles J. Dimitroff. Tumor-Intrinsic Galectin-3 Suppresses Melanoma Metastasis. Journal of Investigative Dermatology 2024; 144(9): 2039 doi: 10.1016/j.jid.2024.02.011
|
| 22 |
Dominic Laaf, Pavla Bojarová, Helena Pelantová, Vladimír Křen, Lothar Elling. Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands. Bioconjugate Chemistry 2017; 28(11): 2832 doi: 10.1021/acs.bioconjchem.7b00520
|
| 23 |
Zhiliang Huang, Zenan Ai, Nan Li, Haofeng Xi, Xucan Gao, Feng Wang, Xiaojun Tan, Haiying Liu. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer. Cancer Biomarkers 2017; 17(4): 445 doi: 10.3233/CBM-160661
|
| 24 |
Sylvia Weilner, Verena Keider, Melanie Winter, Eva Harreither, Benjamin Salzer, Florian Weiss, Elisabeth Schraml, Paul Messner, Peter Pietschmann, Florian Hildner, Christian Gabriel, Heinz Redl, Regina Grillari-Voglauer, Johannes Grillari. Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles. Aging 2016; 8(1): 16 doi: 10.18632/aging.100865
|
| 25 |
Frederick Odun-Ayo, Lalini Reddy. Potential Roles of Modified Pectin Targeting Galectin-3 against Severe Acute Respiratory Syndrome Coronavirus-2. J 2021; 4(4): 824 doi: 10.3390/j4040056
|
| 26 |
Nan Cao, Xuechun Tang, RuiJuan Gao, Liangjingyuan Kong, Jingrong Zhang, Wenjuan Qin, Na Hu, Aimei Zhang, Ketao Ma, Li Li, Jun-Qiang Si. Galectin-3 participates in PASMC migration and proliferation by interacting with TGF-β1. Life Sciences 2021; 274: 119347 doi: 10.1016/j.lfs.2021.119347
|
| 27 |
David J. R. Fulton, Xueyi Li, Zsuzsanna Bordan, Yusi Wang, Keyvan Mahboubi, R. Daniel Rudic, Stephen Haigh, Feng Chen, Scott A. Barman. Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. Antioxidants & Redox Signaling 2019; 31(14): 1053 doi: 10.1089/ars.2019.7753
|
| 28 |
Anna U. Newlaczyl, Lu-Gang Yu. Galectin-3 – A jack-of-all-trades in cancer. Cancer Letters 2011; 313(2): 123 doi: 10.1016/j.canlet.2011.09.003
|
| 29 |
Lei Wang, Dan-Dan Du, Zong-Xue Zheng, Peng-Fei Shang, Xiao-Xia Yang, Chao Sun, Xiao-Yan Wang, Ya-Jie Tang, Xiu-Li Guo. Circulating galectin-3 promotes tumor-endothelium-adhesion by upregulating ICAM-1 in endothelium-derived extracellular vesicles. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.979474
|
| 30 |
Vivek Narayan, Elizabeth W. Thompson, Biniyam Demissei, Jennifer E. Ho, James L. Januzzi, Bonnie Ky. Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease. Journal of the American College of Cardiology 2020; 75(21): 2726 doi: 10.1016/j.jacc.2020.03.067
|
| 31 |
Scott A. Barman, Xueyi Li, Stephen Haigh, Dmitry Kondrikov, Keyvan Mahboubi, Zsuzsanna Bordan, David W. Stepp, Jiliang Zhou, Yusi Wang, Daniel S. Weintraub, Peter Traber, William Snider, Danny Jonigk, Jennifer Sullivan, G. Ryan Crislip, Joshua T. Butcher, Jennifer Thompson, Yunchao Su, Feng Chen, David J. R. Fulton. Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 2019; 316(5): L784 doi: 10.1152/ajplung.00186.2018
|
| 32 |
Martina Sundqvist, Per Wekell, Veronica Osla, Johan Bylund, Karin Christenson, Karin Sävman, Dirk Foell, David A. Cabral, Anders Fasth, Stefan Berg, Kelly L. Brown, Anna Karlsson. Increased Intracellular Oxygen Radical Production in Neutrophils During Febrile Episodes of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome. Arthritis & Rheumatism 2013; 65(11): 2971 doi: 10.1002/art.38134
|
| 33 |
Umadevi V. Wesley, Raghu Vemuganti, Emine R. Ayvaci, Robert J. Dempsey. Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Research 2013; 1496: 1 doi: 10.1016/j.brainres.2012.12.008
|
| 34 |
Hannah Barrow, Jonathan M. Rhodes, Lu‐Gang Yu. The role of galectins in colorectal cancer progression. International Journal of Cancer 2011; 129(1): 1 doi: 10.1002/ijc.25945
|
| 35 |
Hannah Barrow, Xiuli Guo, Hans H. Wandall, Johannes W. Pedersen, Bo Fu, Qicheng Zhao, Chen Chen, Jonathan M. Rhodes, Lu-Gang Yu. Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium. Clinical Cancer Research 2011; 17(22): 7035 doi: 10.1158/1078-0432.CCR-11-1462
|
| 36 |
Yuan-Guo Wang, Seok-Jun Kim, Jung-Hwan Baek, Hyun-Woo Lee, Seo-Young Jeong, Kyung-Hee Chun. Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression. Experimental & Molecular Medicine 2012; 44(6): 387 doi: 10.3858/emm.2012.44.6.044
|
| 37 |
Lei Wang, Xiu-Li Guo. Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression. Biomedicine & Pharmacotherapy 2016; 78: 165 doi: 10.1016/j.biopha.2016.01.014
|
| 38 |
Hafiz Ahmed, Dina M. M. Alsadek. Galectin-3 as a Potential Target to Prevent Cancer Metastasis. Clinical Medicine Insights: Oncology 2015; 9: CMO.S29462 doi: 10.4137/CMO.S29462
|